The Concept of CMR

Epidemiology

Obesity and CVD

Obesity: a key modifiable risk factor for CVD


Page: Go to Previous Page 3 of 6 Go to Next Page

Obesity is a chronic metabolic disorder associated with CVD and increased morbidity and mortality (6-9). Increased body fat is also associated with numerous co-morbidities such as heart disease, type 2 diabetes, stroke, hypertension, dyslipidemia, certain cancers, and sleep apnea (10). In clinical practice, however, physicians are continually challenged by the absence of metabolic abnormalities in some obese patients who have a “normal” metabolic profile despite their excess body fat. Because of this, obesity was long not considered among the “heavyweights” of modifiable CVD risk factors, such as smoking, diabetes, a dyslipidemic state, and hypertension (Figure). In addition, there is no independent association between excess body fat and CVD once the relationship between obesity and hypertension, dyslipidemia and diabetes is taken into account. The absence of an independent association between obesity and CVD could be explained by the fact that obesity is heterogeneous as a CVD risk factor.

When the high-risk form of obesity (abdominal obesity) is considered, its impact on CVD could be approximately equal to that of smoking and may even exceed that of LDL cholesterol (11). It has been suggested that any decrease in smoking-related CVD risk has been offset by the increase in obesity (12). In this regard, Mokdad et al. (13) have recently reported that, if obesity rates continue to skyrocket in the next few years, overweight and obesity caused by poor eating habits and physical inactivity will likely overtake tobacco as the leading preventable cause of mortality. In fact, they estimate that about 365,000 deaths annually are due to sedentary lifestyles and poor nutrition. Unfortunately, the sharp rise in overweight and obesity strongly suggests that this number will increase considerably in the near future. In response, the American Heart Association has reclassified obesity as a major modifiable risk factor for coronary heart disease (CHD) (14).


Reference
Previous Reference
Next Reference
6. Drenick EJ, Bale GS, Seltzer F, et al. Excessive mortality and causes of death in morbidly obese men. JAMA 1980; 243: 443-5.
7. Manson JE, Willett WC, Stampfer MJ, et al. Body weight and mortality among women. N Engl J Med 1995; 333: 677-85.
8. Willett WC, Manson JE, Stampfer MJ, et al. Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range. JAMA 1995; 273: 461-5.
9. Wilson PW, D'Agostino RB, Sullivan L, et al. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002; 162: 1867-72.
10. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. Obes Res 1998; 6 Suppl 2: 51S-209S.
11. Allison DB, Fontaine KR, Manson JE, et al. Annual deaths attributable to obesity in the United States. Jama 1999; 282: 1530-8.
12. Hu FB, Stampfer MJ, Manson JE, et al. Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women. N Engl J Med 2000; 343: 530-7.
13. Mokdad AH, Marks JS, Stroup DF, et al. Actual causes of death in the United States, 2000. Jama 2004; 291: 1238-45.
14. Eckel RH and Krauss RM. American Heart Association call to action: obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee. Circulation 1998; 97: 2099-100.

Document Center


Role of the Dysregulated Endocannabinoid System in Determining Cardiometabolic Risk by Vincenzo Di Marzo, PhD

Role of the Dysregulated Endocannabinoid System in Determining Cardiometabolic Risk by Vincenzo Di Marzo, PhD

More

What is the role of low HDL cholesterol in the elevated CHD risk of metabolic syndrome patients? By Philip J. Barter, MBBS, FRACP, PhD

What is the role of low HDL cholesterol in the elevated CHD risk of metabolic syndrome patients? By Philip J. Barter, MBBS, FRACP, PhD

More

Waist circumference: Getting it right! By Robert Ross, PhD

Waist circumference: Getting it right! By Robert Ross, PhD

More

Hypertrophy and hyperplasia of abdominal adipose tissues in women. Int J Obes (Lond) 2008;32:283-91

Hypertrophy and hyperplasia of abdominal adipose tissues in women. Int J Obes (Lond) 2008;32:283-91

More

Schematic representation of how smoking might add to several mechanisms linking obesity to cardiovascular disease

Schematic representation of how smoking might add to several mechanisms linking obesity to cardiovascular disease

More